| Syed Khurram Raza, MD | |
|
1610 Rte 88, 3rd Fl, Brick, NJ 08724-3018 | |
| (732) 295-6543 | |
| Not Available |
| Full Name | Syed Khurram Raza |
|---|---|
| Gender | Male |
| Speciality | Psychiatry |
| Experience | 39 Years |
| Location | 1610 Rte 88, Brick, New Jersey |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1457542805 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084P0800X | Psychiatry & Neurology - Psychiatry | MD10515 (Rhode Island) | Secondary |
| 2084P0805X | Psychiatry & Neurology - Geriatric Psychiatry | MD10515 (Rhode Island) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Fellowship Health Resources Inc | 8224022546 | 3 |
| Hackensack Meridian Health Medical Group - Specialty Care Pc | 9133032519 | 1090 |
News Archive
Arrowhead Research Corporation (NASDAQ: ARWR), a biopharmaceutical company developing targeted RNAi therapeutics, today announced that it received regulatory approval to begin a Phase 2a clinical trial of ARC-520, its RNAi-based drug candidate for the treatment of chronic hepatitis B virus (HBV) infection.
Iranian researchers recently provided a review of the attempts made to develop safe SARS-CoV-2 vaccines. The researchers outlined potential challenges and concerns, including disease enhancement, virus mutation, and public acceptability. Their work is published in the journal Immunological Investigations.
Influential leaders from the medical and research communities held high-level discussions on biomedical science and technology (S&T) initiatives at the Office of Naval Research (ONR), Sept. 16.
New treatment regimens for multidrug-resistant tuberculosis (MDR-TB) have shown early effectiveness in 85 percent of patients in a cohort that included many people with serious comorbidities that would have excluded them from clinical trials, according to the results of a new international study.
India's patent office "has rejected American drug maker Abbott Laboratories' patent application for an HIV combination drug, allowing low-cost local drug makers to make and sell their generic versions in India and other countries where the medicine is not patented," Economic Times reports (1/4).
› Verified 2 days ago
| Entity Name | Fellowship Health Resources Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1245239680 PECOS PAC ID: 8224022546 Enrollment ID: O20130905000617 |
News Archive
Arrowhead Research Corporation (NASDAQ: ARWR), a biopharmaceutical company developing targeted RNAi therapeutics, today announced that it received regulatory approval to begin a Phase 2a clinical trial of ARC-520, its RNAi-based drug candidate for the treatment of chronic hepatitis B virus (HBV) infection.
Iranian researchers recently provided a review of the attempts made to develop safe SARS-CoV-2 vaccines. The researchers outlined potential challenges and concerns, including disease enhancement, virus mutation, and public acceptability. Their work is published in the journal Immunological Investigations.
Influential leaders from the medical and research communities held high-level discussions on biomedical science and technology (S&T) initiatives at the Office of Naval Research (ONR), Sept. 16.
New treatment regimens for multidrug-resistant tuberculosis (MDR-TB) have shown early effectiveness in 85 percent of patients in a cohort that included many people with serious comorbidities that would have excluded them from clinical trials, according to the results of a new international study.
India's patent office "has rejected American drug maker Abbott Laboratories' patent application for an HIV combination drug, allowing low-cost local drug makers to make and sell their generic versions in India and other countries where the medicine is not patented," Economic Times reports (1/4).
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Syed Khurram Raza, MD 3600 Rte 66, 3rd Fl, Neptune, NJ 07753-2645 Ph: () - | Syed Khurram Raza, MD 1610 Rte 88, 3rd Fl, Brick, NJ 08724-3018 Ph: (732) 295-6543 |
News Archive
Arrowhead Research Corporation (NASDAQ: ARWR), a biopharmaceutical company developing targeted RNAi therapeutics, today announced that it received regulatory approval to begin a Phase 2a clinical trial of ARC-520, its RNAi-based drug candidate for the treatment of chronic hepatitis B virus (HBV) infection.
Iranian researchers recently provided a review of the attempts made to develop safe SARS-CoV-2 vaccines. The researchers outlined potential challenges and concerns, including disease enhancement, virus mutation, and public acceptability. Their work is published in the journal Immunological Investigations.
Influential leaders from the medical and research communities held high-level discussions on biomedical science and technology (S&T) initiatives at the Office of Naval Research (ONR), Sept. 16.
New treatment regimens for multidrug-resistant tuberculosis (MDR-TB) have shown early effectiveness in 85 percent of patients in a cohort that included many people with serious comorbidities that would have excluded them from clinical trials, according to the results of a new international study.
India's patent office "has rejected American drug maker Abbott Laboratories' patent application for an HIV combination drug, allowing low-cost local drug makers to make and sell their generic versions in India and other countries where the medicine is not patented," Economic Times reports (1/4).
› Verified 2 days ago
Dr. Thomas Frank Priolo, MD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 1610 Route 88 Fl 3, Brick, NJ 08724 Phone: 732-295-6543 Fax: 732-295-6204 | |
Olga Ryabinsky, PMHNP Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 940 Cedar Bridge Ave, Brick, NJ 08723 Phone: 855-436-7792 | |
Dr. Carol Ann Dobrzynski, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 2890 Yorktowne Blvd, Brick, NJ 08723 Phone: 732-920-7580 Fax: 732-920-7581 | |
Dr. Mary Celeste Rorro, D.O. Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 970 Route 70, Brick, NJ 08724 Phone: 732-836-6003 | |
Dr. Kristen Clark, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 985 Cedar Bridge Ave, Brick, NJ 08723 Phone: 732-477-5600 | |
Dr. Raymond Baum I, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 445 Brick Blvd, Suite 206, Brick, NJ 08723 Phone: 732-903-7186 Fax: 732-903-7187 |